abstract |
Specific, highly potent 2-oxo-amide based inhibitors of phospholipase A 2 (PLA 2 ) activity are provided. A role for PLA 2 activity in spinally mediated inflammatory processes is established, and a method for treating hyperalgesia and other inflammatory conditions associated with PLA 2 activity is provided. |